Scientific article
Open access

The novel anticoagulants: entering a new era

ContributorsBounameaux, Henri
Published inSchweizerische medizinische Wochenschrift, vol. 139, no. 5-6, p. 60-64
Publication date2009

During the past five decades, anticoagulant therapy has consisted of rapidly acting parenteral drugs (unfractionated heparin [UFH] low-molecular-weight heparins [LMWH]) for prevention of venous thromboembolism and initial treatment of arterial and venous thromboembolism, whereas vitamin K antagonists (VKA) are used for longer term oral treatment. These drugs act by indirectly inhibiting several activated plasma clotting factors (UFH, LMWH) or by blocking the synthesis of some of them (VKA). In recent years, compounds that specifically block activated coagulation factor X (FXa) or thrombin have been developed. Thus, fondaparinux, and its long-acting derivative idraparinux, are administered subcutaneously. These substances inhibit F Xa indirectly via antithrombin. Small molecules have also been developed that directly block FXa (rivaroxaban, apixaban) or thrombin (dabigatran etexilate) following oral administration. In the present review we discuss the currently available evidence supporting the use of these new anticoagulants, in particular rivaroxaban and dabigatran etexilate, in the setting of thromboprophylaxis following major orthopaedic surgery, and the broader perspectives that these new drugs may open up in the next few years.

  • Anticoagulants/pharmacology/*therapeutic use
  • Arthroplasty, Replacement, Hip
  • Arthroplasty, Replacement, Knee
  • Benzimidazoles/therapeutic use
  • Heparin/therapeutic use
  • Heparin, Low-Molecular-Weight/therapeutic use
  • Humans
  • Morpholines/therapeutic use
  • *Orthopedic Procedures
  • Postoperative Complications/*prevention & control
  • Pyridines/therapeutic use
  • Thiophenes/therapeutic use
  • Thromboembolism/*prevention & control
  • Thrombolytic Therapy/*trends
  • Vitamin K/antagonists & inhibitors
Citation (ISO format)
BOUNAMEAUX, Henri. The novel anticoagulants: entering a new era. In: Schweizerische medizinische Wochenschrift, 2009, vol. 139, n° 5-6, p. 60–64. doi: 10.4414/smw.2009.12447
Main files (1)
ISSN of the journal0036-7672

Technical informations

Creation04/23/2012 10:26:41 AM
First validation04/23/2012 10:26:41 AM
Update time03/14/2023 5:22:53 PM
Status update03/14/2023 5:22:53 PM
Last indexation02/12/2024 7:53:37 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack